Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of 3′,4′-(methylenedioxy)propiophenone cas 28281-49-4 in China. Welcome to wholesale bulk high quality 3′,4′-(methylenedioxy)propiophenone cas 28281-49-4 for sale here from our factory. Good service and reasonable price are available.
Announcement
This chemical is prohibited from sale, and our website can only view basic information. We don't sell chemicals here!
October 28, 2025
3′,4′-(Methylenedioxy)propiophenone, molecular formula C10H10O3, CAS number 28281-49-4, is an organic compound with multiple physical properties. At room temperature, it is a solid and may appear as light orange or white in color, which may be affected by purity and storage conditions. This compound has a specific cyclic structure, including a methylene dioxy bridge bond and a benzene ring, as well as an acetone group attached to the benzene ring. May participate in various chemical reactions, such as addition, substitution, oxidation, etc. Its reactivity may be affected by conditions such as catalyst, temperature, and pressure. As an important pharmaceutical intermediate and chemical reagent, it has wide application value in fields such as pharmaceutical experimentation and research, drug design and development, scientific research and education, and industrial applications.

|
|
|
|
Chemical Formula |
C10H10O3 |
|
Exact Mass |
178 |
|
Molecular Weight |
178 |
|
m/z |
178 (100.0%), 179 (10.8%) |
|
Elemental Analysis |
C, 67.41; H, 5.66; O, 26.94 |

3,4-(methylenedioxy) phenylacetone (CAS NO.: 28281-49-4), also known as 3,4-(methylenedioxy) phenylethyl ketone or 3,4-(methylenedioxy) propiophene, with the molecular formula C10H10O3, is a compound composed of a phenylacetone moiety substituted with a methylenedioxy functional group.
Applications in the field of medicine
Capable of synthesizing MDxx compounds, which typically have certain pharmacological activities and can be used to treat certain diseases or as tools for drug research.
It should be noted that some members of the MDxx class of compounds may have addictive or abusive risks, therefore their production and use are subject to strict regulation.
Application in the field of pesticides
In addition to being used as an insecticide, it can also be used to synthesize biocides for controlling the growth and reproduction of various harmful microorganisms.
The application of biocides in agricultural production, food processing, water treatment and other fields is of great significance for ensuring product quality and public safety.
(1) Pesticide synergists:
It can also be used as a pesticide enhancer to enhance the insecticidal, bactericidal, or herbicidal effects of pesticides by increasing their activity or changing their mode of action.
This can not only reduce the use of pesticides and lower production costs, but also minimize environmental pollution and ecological damage.
(2) Other enhancers:
In addition to being used as a synergist in the field of pesticides, it can also be used to synthesize other types of synergists, such as dye synergists, coating synergists, etc. These enhancers can significantly improve the performance and quality of products, meeting market demand.

Synthesis steps
Main raw materials: 1,3-benzodioxole (BDO), Propionic Anhydride, and catalysts (such as anhydrous aluminum chloride AlCl3 or boron trifluoride BF ∝· OEt ₂).
Auxiliary reagents: solvents (such as dichloromethane CH ₂ Cl ₂ or toluene), neutralizing agents (such as sodium bicarbonate NaHCO ∝), desiccants (such as anhydrous sodium sulfate Na ₂ SO ₄), purification solvents (such as ethanol EtOH or ethyl acetate EtOAc).
Step 1: Acylation reaction
Add an appropriate amount of benzodioxolane and propionic anhydride, as well as a catalyst (such as anhydrous aluminum chloride or boron trifluoride), to a dry three necked bottle. Under the protection of inert gas (such as nitrogen N ₂), heat to a certain temperature (usually room temperature to reflux temperature) and stir the reaction for several hours. During this process, the acyl portion of propionic anhydride attacks the active site of benzodioxolane, forming acylation products.
Chemical equation (using anhydrous aluminum chloride as a catalyst as an example):
BDO+Propionic Anhydride → AlCl3 + 3,4-(Methylenedioxy)phenylpropionate+HCl
Note: This equation is a schematic representation and the actual reaction may be more complex, including the generation of multiple by-products.
Step 2: Hydrolysis reaction
Cool the acylation product obtained in the previous step to room temperature, slowly add a neutralizing agent (such as sodium bicarbonate aqueous solution), and neutralize the acidic by-products generated in the reaction (such as hydrochloric acid HCl). The hydrolysis reaction breaks the ester groups in the acylation products, producing carboxylic acids and alcohols. But in this particular synthesis, we expect further conversion to ketones, so the hydrolysis step may not be directly necessary, but depends on subsequent processing.
However, in the acetic anhydride reaction method, the conversion from acylated products to MDP2P is usually achieved through other pathways such as acid catalyzed rearrangement or reduction, rather than direct hydrolysis.
Step 3: Rearrangement or Reduction Reaction
In order to obtain MDP2P from the acylation product, one or more conversion steps are required. This typically involves acid catalyzed rearrangement reactions (such as Claisen rearrangement) or reduction reactions (such as hydrogenation reduction followed by oxidation using metal catalysts such as Pd/C). However, the specific conversion pathway may vary depending on the synthesis strategy.
One possible pathway is through the Claisen rearrangement reaction, which converts the ester groups in the acylation product into ketene intermediates, followed by further chemical transformations (such as oxidation or hydrolysis) to obtain MDP2P. However, please note that this is only an example pathway and not all propionic anhydride reaction methods follow this pathway.
Chemical equation (exemplary Claisen rearrangement reaction):
3,4-(Methylenedioxy)phenylpropionate → Acid Catalysis + Intermediate Enone → Further Transformation + MDP2P
Due to the involvement of multiple complex steps and potential by-products in the Claisen rearrangement and its subsequent transformation, the specific chemical equations and reaction conditions will be very complex and difficult to list in detail here.
Cool the reaction mixture to room temperature and add an appropriate amount of water to quench the reaction. Extract the organic layer using organic solvents such as dichloromethane or ethyl acetate, and dry with a desiccant such as anhydrous sodium sulfate. After removing the desiccant through filtration, the solvent was removed by vacuum distillation to obtain the crude product. Finally, the crude product is further purified by column chromatography, recrystallization, or other purification methods to obtain high-purity MDP2P.
Principles and Discussions of Chemistry
Acetic anhydride, as an acylation reagent, becomes more active in the presence of catalysts such as anhydrous aluminum chloride AlCl3 or boron trifluoride BF ③· OEt ₂, and its acyl portion (i.e., the portion of the propionic acid group after removing one hydroxyl group) becomes more reactive, making it easier to attack the active site of benzodioxolane (BDO). In this process, the catalyst plays a role in reducing the activation energy of the reaction and promoting the formation of acyl cations.
Taking anhydrous aluminum chloride as an example, the reaction may proceed through the following steps:
(1) Formation of acyl cations:
Propionic anhydride loses an oxygen atom on an acyl oxygen bond under the action of aluminum chloride, forming acyl cations and chloride ions.
(2) Electrophilic substitution:
Acyl cations act as electrophilic reagents to attack the electron rich positions of benzodioxolane (usually at positions 2 and 3, but the actual active site may be shifted due to the presence of oxygen atoms), forming carbocation intermediates.
(3) Deprotonation:
Subsequently, another chloride ion or solvent molecule (such as dichloromethane) may act as a base to remove the proton on the carbocation, forming a stable acylation product.
However, it should be noted that the above mechanism is simplified, and actual reactions may involve more complex transition states and intermediates.
Due to the fact that direct conversion from acylation products to MDP2P may not be a direct and efficient pathway, further chemical conversion is usually required. Here we will not delve into Claisen rearrangement as a specific pathway, but instead outline several possible conversion strategies:
(1) Reduction oxidation strategy:
Firstly, the ester group in the acylation product is reduced to an alcohol group (e.g. using LiAlH ₄ for reduction), and then the alcohol group is oxidized to a ketone group through an oxidation reaction (e.g. using chromic acid or potassium permanganate) to obtain MDP2P. But this method may involve multi-step reactions and higher costs.
(2) Acid catalyzed rearrangement or other rearrangement reactions:
Although Claisen rearrangement is not directly applicable, other types of rearrangement reactions (such as Fries rearrangement, Beckmann rearrangement, etc.) may promote the rearrangement of intramolecular groups under specific conditions, thereby approaching the structure of MDP2P. However, these reactions typically require specific functional groups and reaction conditions.
(3) Direct synthesis method:
In some cases, complex rearrangement or reduction steps may be avoided by designing a more direct synthesis route. For example, synthesis can be carried out using other raw materials and reaction conditions that are easily converted into MDP2P.
The post-processing and purification steps are crucial for obtaining high-purity MDP2P. Due to the presence of various by-products and unreacted raw materials in organic synthesis reactions, it is necessary to remove these impurities through appropriate separation and purification techniques. The commonly used purification methods include column chromatography (separation based on the distribution coefficient of compounds between the stationary phase and the mobile phase), recrystallization (purification using the difference in solubility of compounds in different solvents), and distillation (separation using the difference in boiling point of compounds).

Certain derivatives of 3′,4′-(Methylenedioxy)propiophenone have shown promising therapeutic effects as central muscle relaxants in the treatment of spastic paralysis and myalgias caused by motor system disorders. The rationale for the use of these drugs is based on their specific mechanism of action on the central nervous system, which is described in detail and illustrated below:
Principle of medication
Central muscle relaxants mainly act on the central nervous system to achieve muscle relaxation by affecting neurotransmitter transmission and modulating the function of the neural reflex arc. Specifically, these drugs may work in the following ways:
Inhibiting nerve reflexes:
central muscle relaxants inhibit the excitation of polysynaptic reflex arcs, reducing the transmission of nerve impulses in the spinal cord and lower cortical areas of the brain, thereby reducing muscle tension.
Modulation of neurotransmitters:
some central muscle relaxants may reduce the excitatory effect on muscles by interfering with the normal transmission process of neurotransmitters such as acetylcholine, thereby achieving muscle relaxation.
Affecting central nervous system function:
these drugs may also achieve muscle relaxation by affecting the overall function of the central nervous system, such as reducing the excitability of neurons and regulating the balance of neural networks.
Pharmacological composition:
the drug contains a specific 3′,4′-(Methylenedioxy)propiophenone derivative as the active ingredient. At the same time, it may also interfere with the normal transmission process of neurotransmitters such as acetylcholine, further reducing muscle tension.
Mechanism of action:
after entering the body, the derivative is able to rapidly cross the blood-brain barrier into the central nervous system. In the spinal cord and the lower cortical area of the brain, it selectively inhibits the excitation of the polysynaptic reflex arc and reduces the transmission of nerve impulses to the muscles.
Therapeutic effect:
Due to the above mechanism of action, the drug is able to significantly improve muscle tension in patients with spastic paralysis and myalgia caused by motor system disorders. Patients may feel muscle relaxation and pain relief after using the drug, thus improving their quality of life.
It is important to note that although these types of central muscle relaxants are effective in the treatment of spastic paralysis and myalgia, their use must follow strict medical advice. This is because such drugs may have certain side effects and risks, such as excessive relaxation that may lead to muscle weakness, falls, and other accidents. Therefore, when using this type of medication, patients need to pay close attention to their reactions and give timely feedback to their doctors.

International market opportunities
With the acceleration of globalization and the continuous deepening of international trade, its international market opportunities are also increasing day by day. Especially in regions with developed chemical industries such as the Asia Pacific region, Europe, and North America, the demand for high-quality and high-performance chemical raw materials and intermediates continues to grow. This provides a vast market space for its exports.
Challenges and Risks
Although the development prospects of this substance are broad, it also faces some challenges and risks. For example, the increasingly strict environmental regulations will increase the production costs and compliance difficulties of enterprises; The intensification of international market competition will put greater market pressure and competition risks on enterprises. Therefore, enterprises need to continuously strengthen technological innovation and industrial upgrading, improve product quality and reduce costs to cope with these challenges and risks.
Hot Tags: 3′,4′-(methylenedioxy)propiophenone cas 28281-49-4, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, 2 9 9 dimethyl 7 trifluoromethyl 9H fluoren 2 yl 4 4 5 5 tetramethyl 1 3 2 dioxaborolane, tetracaine hcl, 7chlorobenzo h quinoline, tetramisole hcl powder, 2 chlorospiro benzo b fluorene 11 9 fluorene , benzocaine 200mesh






